Revolutionizing Surgical Precision: Genesis Medtech’s World’s First 90° Articulation Powered Stapler Achieves Chinese Approval

SINGAPORE, Jan. 2, 2025 /PRNewswire/ -- Genesis Medtech is proud to announce that iReach Omnia, the world's first powered stapler with 90° articulation capability, has been approved for market release in China by the National Medical Products Administration (NMPA). Independently developed by Genesis Medtech, this innovation addresses key challenges in complex laparoscopic surgeries by enabling surgeons with unprecedented precision and access in tight and deep anatomical positions.

Surgical staplers play a critical role in minimally invasive surgeries by replacing traditional manual sutures, offering more consistent clinical outcomes while reducing infection risk and enhancing surgical efficiency. However, existing staplers, with typical articulation angles from 45° to 60°, face challenges in complex procedures such as low anterior resection or single-port thoracic surgery, where restricted anatomical access in the pelvis or chest cavity demands greater flexibility.

The iReach Omnia sets a new standard in surgical stapling with its 90° articulation capability, providing surgeons with the maneuverability and precision necessary to perform effective stapling even in the most confined spaces. This innovation potentially reduces the need for multiple stapler firings, minimizes weak points in the staple line, thus lowering the risk of anastomotic leakage. By addressing these critical issues, the iReach Omnia empowers surgeons to deliver better patient outcomes in complex procedures such as colorectal and thoracic surgeries.

Sign up for Blog Updates